CU6 · Clarity Pharmaceuticals Ltd.
2.16
AUDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
AU$813.32M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Franking
0%
MQV Rating
5Very Weak
As at 22/09/2026 04:10:03 PM
Price Chart
Description
- All-Companies
- All-Consensus
- GROWTH AUS
- HALO 200
- HALO Consensus Value
- HALO Ords
- HALO Small
- Recent Earnings downgrade
Key Fundamentals
EPS 3 yr Growth
208.00%
EBITDA Margin
N/A
Operating Cashflow
-$93m
Free Cash Flow Return
-67.00%
ROIC
-77.50%
Interest Coverage
N/A
Quick Ratio
16.10
Performance
52 weeks range
Low 1.8 - 5.87
Trade Value (12mth)
AU$1,971,647.00
1 week
0.47%
1 month
-10.04%
YTD
-42.05%
1 year
-42.51%
All time high
8.98
Additional Data
Shares Outstanding (Fully Diluted)
373m
HALO Sector
Healthcare
Next Company Report Date
25-Aug-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
8.52
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Very Weak
Momentum
Price
Weak
Earnings
Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Neutral
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
27 August 26ASXD | |
25 August 26ASXD | |
12 August 26ASXD | |
07 August 26ASXD | |
06 August 26ASXD |
Key Stakeholders
| Name | Title |
| Christopher Graham Roberts | Individual |
| Matthew Harris | Individual |
| Alan John Taylor | Individual |
| Yarrawah Pty Ltd. | Private Company |
| Vantres Pty Ltd. | Private Company |
